Frank Pallone actually said...

Medicaid is an efficient program, its cost per beneficiary is substantially lower than private insurance and Medicare and in recent years, t...

Biosimilars hold enormous potential to offer patients with serious and life-threatening diseases access to more treatment options and potent...

I do worry that it is important in the case of biosimilars or generics that that continue to be a way of reducing drug pricing.

I worry that this inappropriately treats biosimilars like generic drugs and will disincentivize manufacturers from entering the biosimilars ...